Effect of intraductal enterokinase, 5-azacytidine and cycloheximide on pancreatic protein content

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations

Abstract

Intraductal administration of enterokinase [EK] in animals produces acute pancreatitis. 5-Azacytidine [AZA] and cycloheximide [CYC] protect against acute experimental pancreatitis. There is direct correlation between the pancreatic protein content and pancreatic enzyme content, as most of the pancreatic enzymes are present as proteins. In order to elucidate the mechanism of action of EK, AZA and CYC, we gave these agents introductally to rats and 24 hours later determined the protein content on the homogenized pancreas. EK markedly increased the pancreatic protein content (probably by increasing the proteolytic enzyme content). When EK was given with AZA or CYC, there was no increase in the pancreatic protein content. AZA or CYC significantly decreased the pancreatic protein content.

Original languageEnglish (US)
Title of host publicationAmerican Journal of Proctology Gastroenterology and Colon and Rectal Surgery
Volume31
Edition9
StatePublished - 1980
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Effect of intraductal enterokinase, 5-azacytidine and cycloheximide on pancreatic protein content'. Together they form a unique fingerprint.

  • Cite this

    Mann, N. S. (1980). Effect of intraductal enterokinase, 5-azacytidine and cycloheximide on pancreatic protein content. In American Journal of Proctology Gastroenterology and Colon and Rectal Surgery (9 ed., Vol. 31)